60 Stocks Moving In Monday's Mid-Day Session

Gainers

• Morphic Holding, Inc. MORF shares jumped 109.9% to $75.89 after the company reported FY20 sales of $45 million, up from $17 million year over year. The company also reported "positive" interim results from single ascending dose Phase 1 clinical trial of MORF-057.
• electroCore, Inc. ECOR shares climbed 53.4% to $3.3284 after the company announced an Exclusive Distribution Agreement with Medistar following regulatory approval in Australia.
• SOS Limited SOS climbed 46.6% to $6.99. SOS shares dropped 21% on Friday after Hindenberg Research issued a short report on the stock and set a $0 price target.
• Aemetis, Inc. AMTX gained 46.5% to $14.40 after the company disclosed five-year plan targeting $1 billion of revenue by 2025.
• Canaan Inc. CAN rose 37% to $20.75.
• The9 Limited NCTY rose 36.8% to $44.71 after dropping over 20% on Friday. The9 recently acquired 70% equity in Hangzhou SuanLi Technology Co. Ltd. (Interhash), a cryptocurrency cloud mining blockchain software-as-a-service company for approximately $7 million.
• Vector Acquisition Corporation VACQ shares jumped 30% to $13.32. Rocket Lab USA Inc. will go public through a merger with Vector Acquisition in a $4.1 billion deal.
• HCI Group, Inc. HCI gained 29.3% to $74.83 after the company late Friday announced Centerbridge Partners invested $100 million in its TypTap subsidiary.
• Iteris, Inc. ITI climbed 27% to $7.00 after the company announced the Board of Directors unanimously rejected an unsolicited proposal from Rekor Systems.
• ZK International Group Co., Ltd. ZKIN rose 26.4% to $7.60.
• Viomi Technology Co., Ltd VIOT surged 24.7% to $12.94.
• Boingo Wireless, Inc. WIFI jumped 23.7% to $14.10 following news the company will be acquired by Digital Colony for $14 per share in cash.
• Groupon, Inc. GRPN surged 23.2% to $53.46. JP Morgan upgraded Groupon from Underweight to Neutral and announced a $48 price target. Groupon, last week, reported better-than-expected Q4 EPS and sales results.
• PLx Pharma Inc. PLXP gained 22.5% to $9.10 after the company announced it received FDA Approval on its SNDAs for both its VAZALORE 325 mg and 81 mg.
• Apollo Endosurgery, Inc. APEN shares gained 20.4% to $5.64 after the company said it received FDA breakthrough device designation for the orbera intragastric balloon for treatment of patients with NASH.
• The ExOne Company XONE gained 20.3% to $41.04.
• Rayonier Advanced Materials Inc. RYAM jumped 20.1% to $11.11. Rayonier Advanced, last week, reported upbeat quarterly results.
• Marathon Digital Holdings, Inc. MARA gained 19.7% to $36.12 amid continued momentum in Bitcoin.
• ASLAN Pharmaceuticals Limited ASLN rose 19.6% to $5.30 after the company reported positive interim unblinded data from its ongoing Phase 1 study evaluating ASLAN004 to treat moderate to severe atopic dermatitis.
• CleanSpark, Inc. CLSK gained 19.6% to $28.61.
• One Stop Systems, Inc. OSS surged 19.4% to $7.70.
• Ideanomics, Inc. IDEX gained 19% to $3.795.
• Professional Diversity Network, Inc. IPDN gained 18.4% to $3.2789.
• Novan, Inc. NOVN rose 18.3% to $1.68 after dropping 11% on Friday. The company last week reported FY 2020 loss of $0.30 per share.
• Kopin Corporation KOPN gained 18% to $9.86. Kopin is expected to report its next round of earnings this Tuesday, March 02.
• Cullinan Oncology, Inc. CGEM surged 17.9% to $47.67.
• Cars.com Inc. CARS surged 17.4% to $13.70. Cars.com, last week, released Q4 results.
• R. R. Donnelley & Sons Company RRD gained 16.5% to $3.96.
• Brickell Biotech, Inc. BBI shares rose 16.4% to $1.3850. Brickell Biotech is expected to release quarterly results on March 9.
• Riot Blockchain, Inc. RIOT rose 16.1% to $2.37.
• NRG Energy, Inc. NRG surged 16.1% to $42.40 after the company reaffirmed 2021 EBITDA guidance.
• Kubient, Inc. KBNT rose 15.8% to $8.00 after dropping 13% on Friday.
• Holicity Inc. HOL shares rose 14.7% to $16.00 following tweet from Astra highlighting partnership with NASA.
• Pyxis Tankers Inc. PXS rose 14.4% to $1.43. Pyxis Tankers, last week, announced closing of $25.0 million private placement of common stock.
• Zomedica Corp. ZOM rose 14.4% to $2.14 after the company reported a narrower FY20 loss.
• Kirkland's, Inc. KIRK gained 13.6% to $29.55.
• Luokung Technology Corp. LKCO rose 13.6% to $1.7611 after dropping over 14% on Friday. Luokung Technology last month announced a roughly 48 million share common stock offering priced at $2.08 per share.
• WiMi Hologram Cloud Inc. WIMI rose 13.3% to $9.39 after the company disclosed a strategic cooperation with the Dream Classroom program of China Education Television.
• Socket Mobile, Inc. SCKT rose 12.1% to $11.78. Socket Mobile and SpringCard SAS reported a licensing agreement to enable improved contactless customer experiences.
• Qutoutiao Inc. QTT rose 11.5% to $3.89. Qutoutia is expected to report Q4 earnings on March 4.
• Urban Tea, Inc. MYT rose 11% to $4.8586 after dropping 13% on Friday. Urban Tea, last month, appointed new COO and independent director to drive expansion in blockchain and cryptocurrency mining business.
• BriaCell Therapeutics Corp. BCTX rose 10.8% to $3.71. BriaCell reported closing of $25 million public offering.
• AMC Entertainment Holdings, Inc. AMC rose 10.4% to $8.85. AMC Entertainment’s CEO and President Adam Aron, among other top executives, received big bonuses, according to an SEC filing Friday by the world’s largest movie theater chain.
• Salarius Pharmaceuticals, Inc. SLRX rose 9.4% to $1.97. Salarius Pharmaceuticals recently announced plans to expand its phase 1/2 clinical trial of Seclidemstat in patients with Ewing Sarcoma and Ewing-Related Sarcomas.
• XpresSpa Group, Inc. XSPA rose 8.4% to $1.9081. XpresSpa Group and United Airlines, last week, announced the opening of a second XpresCheck COVID-19 testing facility at Newark Liberty International Airport.
• Astrotech Corporation ASTC rose 8.2% to $2.37 after declining 7% on Friday.
• NavSight Holdings, Inc. NSH rose 7.7% to $11.27. Spire Global will go public through a merger with NavSight Holdings in a $1.6 billion deal.
• ChromaDex Corporation CDXC rose 6.7% to $14.86 after dipping over 25% on Friday. ChromaDex, last month, entered into a securities purchase agreement to sell $25 million in common stock via a private placement led by a new international investor.

Check out these big penny stock gainers and losers

Losers

• Athenex, Inc. ATNX shares dipped 50.9% to $5.94 after the company's marketing application for oral paclitaxel to treat metastatic breast cancer was denied by the FDA.
• Ontrak, Inc. OTRK fell 48.5% to $30.34 after the company issued FY21 sales guidance below analyst estimates.
• CorMedix Inc. CRMD fell 39.6% to $9.06 after the FDA has issued a Complete Response Letter for CorMedix’s marketing application seeking approval for DefenCath (taurolidine/heparin catheter lock solution) for catheter-related bloodstream infections. FDA noted concerns at the third-party manufacturing facility after reviewing records, though the agency did not specify the issues.
• Nabriva Therapeutics plc NBRV dipped 18% to $1.96 after the company announced a $25.4 million registered direct offering priced at-the-market under NASDAQ rules.
• Lixte Biotechnology Holdings, Inc. LIXT fell 16% to $4.6925 after jumping 48% on Friday. Lixte holdings is a drug discovery company focused on creating drugs that will help patients with cancer. Lixte’s main product in the pipeline is, per the company’s website, “a developed unique, proprietary, first in-class protein phosphatase inhibitor, LB-100.”
• CLPS Incorporation CLPS dipped 15.3% to $4.97 after the company priced 2,666,666 share registered direct offering at $6 per share.
• Guardion Health Sciences, Inc. GHSI fell 13.4% to $2.6222 following 1:6 reverse stock split.
• BioVie Inc. BIVI fell 13.1% to $27.90.
• Chindata Group Holdings Limited CD shares dropped 11.3% to $20.97. Chindata is expected to report Q4 earnings on March 24.
• Civeo Corporation CVEO fell 9.2% to $17.06.
• Denali Therapeutics Inc. DNLI dropped 6.8% to $66.90. Denali Therapeutics, last week, reported a Q4 profit.
• Zealand Pharma A/S ZEAL fell 6.1% to $33.00 after gaining more than 10% on Friday.